Therefore, we have speculated that it is the anti-MDA5 antibody, produced by viral infection or the release of RNA from impaired or aberrant cells, that may bind to MDA5 pattern recognition receptor to produce pathogenic effect, driving the production of type I interferon signaling consequently leading to inflammation and tissue damage. The gene discussed is IFIH1; the disease is viral infectious disease.